Drug intelligence / Profile preview

Omnimen

Development stage
Unknown
Lead developer
OMNIFARMA
Modality
Small Molecules
Administration
Oral
01

Overview

Omnimen is a multi-ingredient dietary supplement developed by Omnifarma Kiev, specifically formulated to support men's urogenital health. The product contains a synergistic blend of standardized herbal extracts, including Saw Palmetto (*Serenoa repens*), Nettle (*Urtica dioica*), and Pygeum (*Prunus africana*), alongside micronutrients such as Zinc, Selenium, and Lycopene. These components are traditionally used to maintain the functional state of the prostate gland and the lower urinary tract. The mechanism of action involves the inhibition of 5-alpha-reductase and aromatase enzymes, which helps regulate dihydrotestosterone levels and the hormonal balance within prostate tissue. Additionally, the formulation provides anti-inflammatory and antioxidant support, which may alleviate symptoms associated with benign prostatic hyperplasia (BPH) and chronic prostatitis, such as urinary frequency and discomfort.

Brand names
OmnimenОмнімен
02

Targets

SRD5A (Steroid 5-alpha-reductase)CYP19A1 (Aromatase)AR (Adrenergic receptors)

Beyond the preview

Go deeper on Omnimen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Omnimen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call